Benefit-risk balance for marketed drugs: evaluating safety signals

Benefit-risk balance for marketed drugs: evaluating safety signals

Zapisane w:

Opis bibliograficzny
Korporacja:	Council for International Organizations of Medical Sciences (CIOMS)
Format:	Książka
Język:	English
Wydane:	Geneva Council for International Organizations of Medical Sciences (CIOMS) 1998
Hasła przedmiotowe:	Drugs Pharmaceutic Preparations Pharmaceutical Products Preparations, Pharmaceutical
Dostęp online:	Visit NHRC Library
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy

Martindale: the complete drug reference
od: Parfitt, Kathleen
Wydane: (1999)

WHO drug information.
Wydane: (2000)

WHO expert committee on specifications for pharmaceutical preparations
Wydane: (2006)

International nonproprietary names (INN) for pharmaceutical substances : lists 1-65 of proposed INN and lists 1-31 of recommended INN : cumulative list no. 8 = Dénominations communes internationales (DCI) pour les substances pharmaceutiques : listes 1-65 de DCI proposées et listes 1-31 de DCI recommandées : liste récapitulative no. 8.
Wydane: (1992)

WHO expert committee on specifications for pharmaceutical preparations
Wydane: (2011)

WHO Expert Committee on Specifications for Pharmaceutical Preparations
Wydane: (2012)

USP DI. Approved drug products and legal requirements.
Wydane: (1995)

Where there are no pharmacists : a guide to managing medicines for all health workers /
od: Andersson, Sarah
Wydane: (2010)

Managing drug supply : the selection, procurement, distribution, and use of pharmaceuticals. the selection, procurement, distribution, and use of pharmaceuticals.
Wydane: (1997)

Pharmacology : a patient-centered nursing process approach /
od: Kee, Joyce LeFever, i wsp.

Drug calculations : ratio and proportion problems for clinical practice /
od: Seltzer, Meta Brown, i wsp.

Effective drug regulation a multicountry study /
od: Ratanawijitrasin, Sauwakon
Wydane: (2002)

WHO Expert Committee on Specifications for Pharmaceutical Preparations : forty-eighth meeting report /

Preparation of hazardous waste inventory
od: DEVS Consult Nepal (P) Ltd.
Wydane: (2013)

Client satisfaction and quality of curative services for sick children in Nepal: further analysis of the 2015 Nepal Health Facility Survey: DHS further analysis reports No. 114.
od: Acharya,Kiran
Wydane: (2018)

Regulatory Situation of Herbal Medicines
Wydane: (1998)

A text book of pharmacognosy.
od: Raut, Bechan, i wsp.
Wydane: (2007)

Status of Ayurvedic Medicines Available in the Markets of Nepal
od: Adhikari, SM, i wsp.
Wydane: (2016)

The Selection and Use of Essential Medicines Reports of the WHO Expert Committee on the Selection and Use of Essential Medicines and the 3rd WHO Model list of essential medicines for children
Wydane: (2012)

AHFS drug information 2000
od: Snow, Elaine, K
Wydane: (2000)

Safety requirements for the first use of new drugs and diagnostic agents in man : a review of safety issues in early clinical trials of drugs.
Wydane: (1983)

Final Report on Development of Profile of Toxic Waste Products in Nepal
od: Nepal Health Research Council (NHRC), i wsp.
Wydane: (2013)

Serotyping and antibiotic resistance profile of common bacterial isolates causing gastroenteritis.
od: Yadav, Raju
Wydane: (2016)

Ensuring balance in national policies on control substances: Guidelines for availability and accessibility of controlled medicines
Wydane: (2011)

Clinical trials: study design, endpoints and biomarkers, drug safety, and FDA and ICH guidelines
od: Brody, Tom
Wydane: (2016)

Evaluation of certain veterinary drug residues in food
Wydane: (2000)

WHO Expert Committee on biological standardization sixty-fourth meeting report /

Study on the Projection and Management of Health Care Professionals for the Next Ten Years
od: Aryal, BK, i wsp.
Wydane: (2016)

Impact of educational intervention on knowledge and practice of safety precaution of cytotoxic drugs administration among nurse.
od: Pande, Sarala
Wydane: (2011)

Status of Ayurvedic medicines available in the markets of Nepal
od: Adhikari, Shyam Mani
Wydane: (2008)

Status of Ayurvedic Medicines Available in the Markets of Nepal
od: Adhikari, Shyam Mani, Dr.
Wydane: (2012)

Evaluation of certain veterinary drug residues in food: Forty- second report of the joint FAO/WHO expert committee on food additives
Wydane: (1995)

Fundamentals of Clinical Trials /
od: Friedman, Lawrence M, i wsp.
Wydane: (2015)

Evaluation of certain veterinary drug residues in food : seventy-fifth[75th] report of the Joint FAO/WHO Expert Committee on Food Additives
Wydane: (2012)

The use of essential drugs : ninth report of the WHO Expert Committee (including the revised Model list of essential drugs).
Wydane: (2000)

Drug policy in the Americas
od: Smith, Peter H.
Wydane: (1992)

Ensuring balance in national policies on controlled substances Guidance for availability and accessibility of controlled medicines
Wydane: (2011)

Ensuring balance in national policies on controlled substances Guidance for availability and accessibility of controlled medicines
Wydane: (2011)

Iodized salt social marketing campaign (ISMAC): Baseline Study
od: Poudel, Krishna Prasad
Wydane: (2015)

Public Health Care Expenditures in Nepal: Review, Analysis and Assessment
od: Maskay, NM, i wsp.
Wydane: (2016)